Clinical and economic benefits of professional CGM among people with type 2 diabetes in the United States: analysis of claims and lab data
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Medical Economics"
DOI: 10.1080/13696998.2017.1390474
Abstract: Abstract Background: It is estimated that one in 10 people in the US have a diagnosis of diabetes. Type 2 diabetes accounts for 95% of all cases in the US, with annual costs estimated to… read more here.
Keywords: difference; year; cgm; type diabetes ... See more keywords